Hui-Zin Tu
Fooyin University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hui-Zin Tu.
Antimicrobial Agents and Chemotherapy | 2003
Tsi-Shu Huang; Susan Shin-Jung Lee; Hui-Zin Tu; Wen-Kuei Huang; Yao-Shen Chen; Chung-Kai Huang; Shue-Ren Wann; Hsi-Hsun Lin; Yung-Ching Liu
ABSTRACT A total of 76 clinical Mycobacterium tuberculosis isolates from Taiwan were tested for pyrazinamidase activity, pyrazinamide susceptibility, and pncA mutations. Frequency of resistance to PZA rose with increases in resistance to first-line drugs. Of 17 pyrazinamide-resistant strains, 7 (3 of which had not been previously described) possessed mutations in the pncA gene.
Diagnostic Microbiology and Infectious Disease | 2003
Tsi-Shu Huang; Wen-Kuei Huang; Susan Shin-Jung Lee; Hui-Zin Tu; Shu-Huei Chang; Yung-Ching Liu
The ability to rapidly detect tubercle bacilli in respiratory secretions was determined for the BDProbeTEC ET Mycobacterium tuberculosis Complex Direct Detection Assay in comparison with the acid-fast smear (AFS). A total of 267 respiratory specimens obtained from 89 patients were evaluated. The DTB assay was positive in 70 of 78 culture positive specimens (89.7%) and 12 of 177 culture negative specimens (6.8%). The AFS was positive in 33 of 78 culture positive specimens (42.3%) and 3 of 186 culture negative specimens (1.6%). The sensitivity, specificity, positive predictive value, and negative predictive value of DTB assay were 89.7%, 93.7%, 85.4%, and 95.7%, respectively. The sensitivity of a single DBT (74.4%) was 2.1-times greater than three AFS (35.9%). The greater cost of the DTB assay compared to the AFS was compensated by its valuable information for the diagnosis and control of tuberculosis. These results demonstrated the clinical usefulness of the DTB assay for the rapid diagnosis of tuberculosis in respiratory specimens.
PLOS ONE | 2018
Tsi-Shu Huang; Chia-Chien Lee; Hui-Zin Tu; Susan Shin-Jung Lee
Background Rapid identification of mycobacteria is important for timely treatment and the implementation of public health measures. The MGIT system ensures rapid detection of mycobacteria, but identification is usually delayed by days to weeks due to further subculture on solid medium. Matrix-assisted laser desorption time-of-flight mass spectrometry (MALDI-TOF MS) was demonstrated to effectively identify mycobacteria isolates subcultured from solid or liquid media. Reports of identification directly from MGIT broths of both sterile and non-sterile clinical specimens, omitting the subculture step, were limited and not satisfactory before. Our identification method dramatically shortened delay from detection to identification of mycobacteria. Methodology We assessed the performance of the Vitek MS IVD version 3.0 for direct identification of NTM and M.tuberculosis from primary MGIT cultures, and assessed two sample preparation methods. Results Direct identification of NTM from positive MGIT broths, using MALDI-TOF VITEK MS with IVD v.3.0, generated high rates of acceptable results reaching 96.4% (80/83), and up to 100% (83/83) for sample preparations including a 0.1% SDS washing step. The sensitivity of VITEK MS to identify M.tuberculosis from MGIT tubes was 58/72 (80.6%), when using immunochromatography (ICA) test as gold standard. A characteristic colony clumping, wool-like appearance was observed in 48, and all 58 (100%) were correctly identified as M.tuberculosis using MALDI-TOF. The detection rate of M.tuberculosis complex was low (10/24, 41.6%) in the 24 MGIT tubes that was polymicrobial. Our method significantly reduced both the reagent cost and turnaround time. Conclusions Based on a simplified protocol, we showed that MALDI-TOF MS can be used for rapid identification of NTM directly from primary MGIT cultures within the routine clinical laboratory workflow. However, we recommend an initial ICA test to screen for M.tuberculosis complex, due to a low identification rate of M. tuberculosis in the presence of polymicrobial cultures using MALDI-TOF.
Journal of Antimicrobial Chemotherapy | 2005
Tsi-Shu Huang; Calvin M. Kunin; Susan Shin-Jung Lee; Yao-Shen Chen; Hui-Zin Tu; Y. C. Liu
Annals of Clinical and Laboratory Science | 2002
Tsi-Shu Huang; Hui-Zin Tu; Susan Shin-Jung Lee; Wen-Kuei Huang; Yung-Ching Liu
Journal of Antimicrobial Chemotherapy | 2004
Tsi-Shu Huang; Susan Shin-Jung Lee; Hui-Zin Tu; Wen-Kuei Huang; Yao-Shen Chen; Chung-Kai Huang; Shue-Ren Wann; Hsi-Hsun Lin; Y. C. Liu
Annals of Clinical and Laboratory Science | 2003
Hui-Zin Tu; Shu-Huei Chang; Tsi-Shu Huaug; Wen-Kuei Huaug; Yung-Ching Liu; Susan Shin-Jung Lee
Annals of Clinical and Laboratory Science | 2005
Tsi-Shu Huang; Yao-Shen Chen; Susan Shin-Jung Lee; Hui-Zin Tu; Yung-Ching Liu
Annals of Clinical and Laboratory Science | 2007
Tsi-Shu Huang; Yung-Ching Liu; Hui-Zin Tu; Cheng-Len Sy; Yao-Shen Chen; Bao-Chen Chen
Archive | 2005
Tsi-Shu Huang; Yao-Shen Chen; Susan Shin-Jung Lee; Hui-Zin Tu; Yung-Ching Liu